US Stock MarketDetailed Quotes

KRON Kronos Bio

Watchlist
  • 1.350
  • +0.010+0.75%
Trading Jul 26 09:44 ET
81.13MMarket Cap-678P/E (TTM)

About Kronos Bio Company

Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases. The company was founded by Arie S. Belldegrun, Joshua A. Kazam, David M. Tanen, and Christopher Wilfong on June 2, 2017 and is headquartered in San Mateo, CA.

Company Profile

SymbolKRON
Company NameKronos Bio
Listing DateOct 9, 2020
Issue Price19.00
Founded2017
CEOProfessor Dr. Norbert W. Bischofberger, PhD
MarketNASDAQ
Employees62
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1300 So. El Camino Real,Suite 300
CitySan Mateo
ProvinceCalifornia
CountryUnited States of America
Zip Code94402
Phone1-650-781-5200

Company Executives

  • Name
  • Position
  • Salary
  • Professor Dr. Norbert W. Bischofberger, PhD
  • Director, President and Chief Executive Officer
  • 1.76M
  • Dr. Deborah Knobelman, PhD
  • Chief Operations Officer, Principal Accounting Officer and Chief Financial Officer
  • --
  • Dr. Elizabeth A. Olek, D.O.,M.P.H.
  • Senior Vice President, Clinical Development
  • --
  • Allison Frisbee, J.D.
  • Senior Vice President, Corporate Operations and Legal
  • --
  • Charles Y. Lin, PhD
  • Senior Vice President, Research and Development
  • --
  • Dr. Arie S. Belldegrun, F.A.C.S.,M.D.
  • Chairman of the Board
  • 117.20K
  • Joshua A. Kazam
  • Director
  • 74.80K
  • David M. Tanen
  • Director
  • 74.80K
  • Katherine Vega Stultz
  • Independent Director
  • 105.68K
  • Elena H. Ridloff, C.F.A.
  • Independent Director
  • 89.17K
  • Roshawn A. Blunt
  • Independent Director
  • 79.80K
  • Dr. Taiyin Yang, PhD
  • Independent Director
  • 88.70K
  • Dr. Roger D. Dansey, M.D.
  • Independent Director
  • 97.52K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg